These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4316242)

  • 21. Effect of polycations on sensitivity of BALD-3T3 cells to murine leukemia and sarcoma virus infectivity.
    Manning JS; Hackett AJ; Darby NB
    Appl Microbiol; 1971 Dec; 22(6):1162-3. PubMed ID: 4332936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of interferon in L cells by polyinosinic-polycytidylic acid in the presence of cationic compounds. I. Polycations.
    Wacker A; Lodemann E; Diederich J; Mohrbutter K; Lauschke U
    Arch Gesamte Virusforsch; 1972; 36(1):71-9. PubMed ID: 5012436
    [No Abstract]   [Full Text] [Related]  

  • 23. Dissociation of interferon effects on murine leukemia virus and encephalomyocarditis virus replication in mouse cells.
    Czarniecki CW; Sreevalsan T; Friedman RM; Panet A
    J Virol; 1981 Feb; 37(2):827-31. PubMed ID: 6163874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccinia-mediated rescue of encephalomyocarditis virus from the inhibitory effects of interferon.
    Whitaker-Dowling P; Youngner JS
    Virology; 1986 Jul; 152(1):50-7. PubMed ID: 2424172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of polycations on the early stages of reovirus infection.
    Loh PC; Hashiro GM; Yau JT
    Microbios; 1977; 19(77-78):213-29. PubMed ID: 617209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of interferons and poly(I):poly(C) on the pathogenesis of the diabetogenic variant of encephalomyocarditis virus in different mouse strains.
    Giron DJ; Agostini HJ; Thomas DC
    J Interferon Res; 1988 Dec; 8(6):745-53. PubMed ID: 2466089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Action of human leukocyte and immune interferons on the reproduction and cytopathogenic effect of the encephalomyocarditis virus in mice].
    Mentkevich LM; Zhdanova LV; Meshkova EN
    Vopr Virusol; 1984; 29(5):582-5. PubMed ID: 6097046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of biological and synthetic polymers on BK virus infectivity and hemagglutination.
    Sinibaldi L; Pietropaolo V; Goldoni P; Di Taranto C; Orsi N
    J Chemother; 1992 Feb; 4(1):16-22. PubMed ID: 1328555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunofluorescent studies on the effect of antiviral substances on virus multiplication. 3. Effect of actidione on the multiplication of Mengo virus.
    Veckenstedt A; Wagner M
    Arch Gesamte Virusforsch; 1971; 33(1):49-60. PubMed ID: 4325976
    [No Abstract]   [Full Text] [Related]  

  • 30. Enhancement of antiviral protection against encephalomyocarditis virus by a combination of isoprinosine and interferon.
    Chany C; Cerutti I
    Arch Virol; 1977; 55(3):225-31. PubMed ID: 74245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-viral activity of single-stranded homopolynucleotides against encephalomyocarditis virus and Semliki Forest virus in adult mice without interferon induction.
    Stebbing N; Grantham CA; Carey NH
    J Gen Virol; 1976 Jan; 30(1):21-39. PubMed ID: 173799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of cell receptors and simple sugar inhibitors during encephalomyocarditis virus-cell union.
    Kunin CM
    J Virol; 1967 Apr; 1(2):274-82. PubMed ID: 4318947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infectivity of liposomally encapsulated nucleic acids isolated from EMC virus and scrapie-infected mouse brain.
    Manning EJ; Millson GC
    Intervirology; 1983; 20(2-3):164-8. PubMed ID: 6313546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral activity of tobacco smoke condensate on encephalomyocarditis infection in mice.
    Furusawa E; Ramanathan S; Suzuki N; Tani S; Furusawa S
    Antimicrob Agents Chemother; 1973 Apr; 3(4):484-7. PubMed ID: 4364177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociable antiviral activities directed against cardioviruses are expressed in L cells treated with interferon.
    Monahan SJ; Simon E
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2299-303. PubMed ID: 1383407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmissibility of the D variant of encephalomyocarditis virus (EMC-D) in mice.
    Doi C; Takeda M; Hirasawa K; Doi K
    Lab Anim; 1993 Jul; 27(3):222-5. PubMed ID: 8396185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein synthesis and membrane integrity in interferon-treated HeLa cells infected with encephalomyocarditis virus.
    Muñoz A; Carrasco L
    J Gen Virol; 1981 Sep; 56(Pt 1):153-62. PubMed ID: 6170728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation of incubation temperature to interferon production in mouse peritoneal cells infected with Newcastle disease virus.
    Waschke K; Lackovic V; Borecký L
    Acta Virol; 1969 Sep; 13(5):387-92. PubMed ID: 4398703
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of interferon during viremia. I. Production of circulating interferon.
    Baron S; Buckler CE; McCloskey RV; Kirschstein RL
    J Immunol; 1966 Jan; 96(1):12-6. PubMed ID: 4285558
    [No Abstract]   [Full Text] [Related]  

  • 40. Duration of prophylactic effect of statolon against mengovirus in mice.
    Schmidt JP; Pindak FF
    Appl Microbiol; 1968 Mar; 16(3):468-9. PubMed ID: 4297000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.